Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial.

Judith LeblancLisbeth Dusserre-TelmonAnthony ChauvinTabassome SimonChiara E SabbatiniKarla HemmingVittoria ColizzaLaurence BérardJérome ConvertSonia LazazgaCarole JegouNabila TaibiSandrine DauthevilleDamien ZaghiaCamille GerlierMuriel DomergueFlorine LarrouturouFlorence BonnetArnaud FontanetSarah SalhiJérôme Le GoffAnne-Claude Crémieuxnull nullnull null

Published in: PLoS medicine (2023)

Trial registration number: ClinicalTrials.gov NCT04756609.

Keyphrases

sars cov
phase iii
open label
phase ii
double blind
placebo controlled
study protocol
clinical trial
coronavirus disease
respiratory syndrome coronavirus
randomized controlled trial